Antibodies Against Programmed Cell Death Protein 1 (PD1) and Uses Thereof
Copyright © Targeted News Service 2025
2025-11-25
ALEXANDRIA, Virginia, Nov. 25 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, Florida has been assigned a patent (No. US 12479908 B2, initially filed March 30, 2020) developed by Jose Conejo-Garcia, Tampa, Florida, and Subir Biswas, Tampa, Florida, for "Antibodies against programmed cell death protein 1 (PD1) and uses thereof." . . .
